arrow
K

Klaus H. Metzeler

Leipzig University Medical Center
H指数:56
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bone health in myelodysplastic neoplasms: results from the prospective longitudinal BoHemE study

骨髓增生异常性肿瘤的骨骼健康:来自前瞻性纵向BoHemE研究的结果

Leukemia
IF13.4
2026-10-090
OAAI
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist

一种涵盖无细胞系的亚组、可连续移植的急性髓系白血病PDX模型平台

2026-10-050
OAAI
The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model

SPIZ研究:一项随机对照试验的合理性与方案,旨在通过数字化支持、跨区域和跨部门护理模式优化细胞疗法后患者的多学科护理

2026-09-260
OAAI
Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trials

卡那奴单抗或依马伏塞替治疗低危骨髓增生异常综合征贫血:CANFIRE和LUCAS两项2期、开放标签、多中心试验的结果

2026-09-160
OAAI
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study

吉列替尼与异基因造血干细胞移植序贯治疗复发/难治FMS样酪氨酸激酶3(FLT3)突变急性髓系白血病患者的多中心真实世界研究

2026-09-050
OAAI
Low muscle quality, but not muscle mass, in abdominal CT-scans associates with adverse outcomes in AML patients undergoing an allogeneic stem cell transplantation

腹部CT扫描显示肌肉质量低而非肌肉量与接受异基因干细胞移植的AML患者的不良预后相关

2026-08-130
OAAI
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells

克隆性造血不影响嵌合抗原受体(CAR)T细胞的制备

2026-06-030
OAAI
Impact of Renal Impairment and Lymphodepletion Regimen on Outcomes after CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma

肾损伤和淋巴清除方案对复发/难治性多发性骨髓瘤CAR T细胞治疗预后的影响

2026-05-160
PRE
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma

克隆性造血的复发、TP53 扩增以及之前的来那度胺治疗是驱动多发性骨髓瘤患者 CAR-T 治疗后髓系障碍的因素。

Leukemia
IF13.4
2026-03-240
OAAI
MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel

MyCARdiac评分:整合心脏成像和生物标志物以预测接受cilta-cel治疗的RRMM患者的结局

Leukemia
IF13.4
2026-02-170
OAAI
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia

FLT3-ITD突变急性髓系白血病中髓系发育异常相关基因突变的预后影响

Leukemia
IF13.4
2026-02-090
OAAI
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia – a HARMONY study

解析具有预后意义的NPM1突变成人急性髓系白血病的共突变模式——一项HARMONY研究

Leukemia
IF13.4
2026-01-140
OA
Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis

CT放射组学分析与多发性骨髓瘤患者造血细胞动员之间的关联:一项探索性分析

2026-01-010
OA
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation

12 Gy全身照射和环磷酰胺的顺序不会影响接受骨髓 ablative 异基因干细胞移植的AML患者的结局

2025-12-020
OAAI
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients

4978例接受强化治疗的AML欧洲患者队列中,髓系发育异常相关基因突变的不同预后影响

Leukemia
IF13.4
2025-10-270
OA